Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

March 28, 2015 12:32 PM ET

Healthcare Equipment and Supplies

Company Overview of Beckman Coulter, Inc.

Company Overview

Beckman Coulter, Inc. develops, manufactures, and markets diagnostic systems that automate complex biomedical testing. The company’s research and discovery products and services include capillary electrophoresis, centrifugation, centrifugation (analytical), chemiluminescence, electrochemistry, flow cytometry, genetic analysis, genomic services, immunoassay, liquid handlers, next generation library construction, nucleic acid sample preparation, particle characterization, research automation, single cell PCR, and spectrophotometers for use in cellular solutions, drug discovery and development, genetic analysis, genomic services, protein analysis, and small molecule analysis. Its clinical produ...

250 South Kraemer Boulevard

Brea, CA 92821

United States

Founded in 1935

11,900 Employees





Key Executives for Beckman Coulter, Inc.

Chief Executive officer, President and Interim Diagnostic Division President
Age: 64
Chief Financial Officer and Senior Vice President
President of Life Science Division
Age: 50
President of Europe Commercial Operations
Compensation as of Fiscal Year 2014.

Beckman Coulter, Inc. Key Developments

Beckman Coulter to Shut Galway Facility with the Loss of 140 Jobs

Beckman Coulter announced to shut its Galway facility with the loss of 140 jobs. The company has said up to 80 staff will be offered redeployment at its facility in Co Clare.

Beckman Coulter Receives Contract for Z1 Dual Threshold Particle Counter Maintenance from University of Mary Washington

University of Mary Washington has awarded a contract (No. 14-59) for Z1 dual threshold particle counter maintenance agreement (93863) to Beckman Coulter on May 22, 2014.

Beckman Coulter Diagnostics Announces Availability of New Prostate Cancer Blood Test

Beckman Coulter Diagnostics has announced the availability of the Prostate Health Index, or phi, a non-invasive blood test that is reportedly three times more specific in detecting prostate cancer than PSA, or prostate-specific antigen. The new test's accuracy decreases the need for many men who test positive for elevated PSA levels to undergo a biopsy in order to achieve a reliable diagnosis. Results of a multi-center clinical study found a 31% reduction in unnecessary biopsies due to false-positives as a result of using the phi test. The phi test is available to physicians nationwide through Innovative Diagnostics Laboratory (IDL), a national clinical reference laboratory specializing in personalized blood-based testing to find, understand and treat cancer.

Similar Private Companies By Industry

Company Name Region
Nanamed, LLC United States
Spiracur Inc. United States
Ateb, Inc. United States
Ridge Diagnostics, Inc. United States
Satisloh North America, Inc. United States

Recent Private Companies Transactions

July 16, 2014
Siemens Healthcare Diagnostics, Clinical Microbiology Business
April 22, 2014
Xitogen Technologies, Inc. and Cytojene Corporation

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Beckman Coulter, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at